Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
CD48_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
P09326
EntryName
CD48_HUMAN
FullName
CD48 antigen
TaxID
9606
Evidence
evidence at protein level
Length
243
SequenceStatus
complete
DateCreated
1989-07-01
DateModified
2021-06-02
Ontological Relatives
Genes
CD48
GO terms
Show/Hide Table
GO
Name
GO:0002819
regulation of adaptive immune response
GO:0003823
antigen binding
GO:0005886
plasma membrane
GO:0006952
defense response
GO:0016020
membrane
GO:0031225
anchored component of membrane
GO:0031226
intrinsic component of plasma membrane
GO:0038023
signaling receptor activity
GO:0045121
membrane raft
GO:0050900
leukocyte migration
GO:0070062
extracellular exosome
Subcellular Location
Show/Hide Table
Subcellular Location
Cell membrane
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR003599
Immunoglobulin subtype
Domain
Domain
IPR007110
Immunoglobulin-like domain
Domain
Domain
IPR013106
Immunoglobulin V-set domain
Domain
Domain
IPR013783
Immunoglobulin-like fold
Family
Homologous superfamily
IPR033548
CD48 antigen
Family
Family
IPR036179
Immunoglobulin-like domain superfamily
Family
Homologous superfamily
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
12 interactions
Interactor
Partner
Sources
Publications
Link
CD48_HUMAN
EF1D_HUMAN
BioGRID, HPRD, IntAct
16169070
details
CD48_HUMAN
BRX1_HUMAN
BioGRID, HPRD
16169070
details
CD48_HUMAN
CD2_HUMAN
BioGRID, HPRD
12356317
details
CD48_HUMAN
CD244_HUMAN
HPRD, IntAct, UniProt
11163399
15153464
16002700
18296487
9834056
details
CD48_HUMAN
CD48_HUMAN
UniProt
16002700
details
CD48_HUMAN
LCK_HUMAN
BioGRID, HPRD
12007789
8104794
details
CD48_HUMAN
SQSTM_HUMAN
BioGRID
26043024
details
CD48_HUMAN
GNAI3_HUMAN
HPRD
8650218
details
CD48_HUMAN
I18RA_HUMAN
HPRD
15760905
details
CD48_HUMAN
IL18R_HUMAN
HPRD
15760905
details
CD48_HUMAN
CD3Z_HUMAN
HPRD
16049493
details
CD48_HUMAN
FYN_HUMAN
HPRD
8104794
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree